Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor

PLoS Pathogens

Volumn 6, Issue 7, 2010, Pages 1-9

  Zhang, Zhen ^a   Selariu, Anca ^a   Warden, Charles ^a   Huang, Grace ^a   Huang, Ying ^a   Zaccheus, Oluleke ^a   Cheng, Tong ^b   Xia, Ningshao ^b   Zhu, Hua ^a  

^a UMNDJ Newark ^*  (United States)

^b XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN ORF 7; PROTEOME; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; ESCHERICHIA COLI; GENE DELETION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; OPEN READING FRAME; REPORTER GENE; VARICELLA ZOSTER VIRUS; VIRUS MUTANT; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); HERPESVIRIDAE; HUMAN HERPESVIRUS 3;

EID: 77957684245     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000971     Document Type: Article

References (71)

1. Abendroth A, Arvin A (1999) Varicella-zoster virus immune evasion. Immunol Rev 168: 143-156.
2. Cohen JI, Straus SE, Arvin AM (2007) Varicella-Zoster Virus Replication, Pathogenesis, and Management. In: Knipe DM, Howley PM, eds. Fields Virology. 5th ed. PhiladelphiaPA: Lippincott Williams & Wilkins. pp 2773-2818.
3. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342: 635-645.
4. Centers for Disease Control and Prevention (2003) Decline in annual incidence of varicella-selected states, 1990-2001. MMWR Morb Mortal Wkly Rep 52: 884-885.
5. Gershon AA, Arvin AM, Shapiro E (2007) Varicella vaccine. New England Journal of Medicine 356: 2648-2649.
6. Lopez AS, Kolasa MS, Seward JF (2008) Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program. J Infect Dis 197 Suppl 2: S76-S81.
7. Marin M, Meissner HC, Seward JF (2008) Varicella prevention in the United States: a review of successes and challenges. Pediatrics 122: e744-751.
8. Seward JF, Watson BM, Peterson CL, Mascola L, Peloso JW, et al. (2002) Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. Jama-Journal of the American Medical Association 287: 606-611.
9. Vazquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, et al. (2004) Effectiveness over time of varicella vaccine. Jama-Journal of the American Medical Association 291: 851-855.
10. Vazquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, et al. (2001) The effectiveness of the varicella vaccine in clinical practice. New England Journal of Medicine 344: 955-960.
11. Galil K, Lee B, Strine T, Carraher C, Baughman AL, et al. (2002) Outbreak of varicella at a day-care center despite vaccination. New England Journal of Medicine 347: 1909-1915.
12. Gershon AA, Steinberg SP, Gelb L, Galasso G, Borkowsky W, et al. (1984) Live Attenuated Varicella Vaccine - Efficacy for Children with Leukemia in Remission. Jama-Journal of the American Medical Association 252: 355-362.
13. Izurieta HS, Strebel PM, Blake PA (1997) Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. Jama-Journal of the American Medical Association 278: 1495-1499.
14. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, et al. (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New England Journal of Medicine 352: 2271-2284.
15. Arvin AM (2001) Varicella-Zoster Virus. In: Knipe DM, Howley PM, eds. Fields Virology. PhiladelphiaPA: Lippincott Williams & Wilkins. pp 2731-2767.
16. Niizuma T, Zerboni L, Sommer MH, Ito H, Hinchliffe S, et al. (2003) Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J Virol 77: 6062-6065.
17. Cohen JI, Seidel KE (1993) Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci U S A 90: 7376-7380.
18. Moffat JF, Stein MD, Kaneshima H, Arvin AM (1995) Tropism of varicellazoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol 69: 5236-5242.
19. Zhang Z, Rowe J, Wang W, Sommer M, Arvin A, et al. (2007) Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol 81: 9024-9033.
20. Taylor SL, Moffat JF (2005) Replication of varicella-zoster virus in human skin organ culture. J Virol 79: 11501-11506.
21. Arvin AM (2006) Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model. Herpes 13: 75-80.
22. Zhang Z, Huang Y, Zhu H (2008) A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system. J Virol Methods 148: 197-204.
23. Defechereux P, Melen L, Baudoux L, Merville-Louis MP, Rentier B, et al. (1993) Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product. J Virol 67: 4379-4385.
24. Moriuchi H, Moriuchi M, Smith HA, Cohen JI (1994) Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27. J Virol 68: 1987-1992.
25. Moriuchi H, Moriuchi M, Straus SE, Cohen JI (1993) Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA. J Virol 67: 4290-4295.
26. Perera LP, Mosca JD, Sadeghi-Zadeh M, Ruyechan WT, Hay J (1992) The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter. Virology 191: 346-354.
27. Sato B, Ito H, Hinchliffe S, Sommer MH, Zerboni L, et al. (2003) Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo. J Virol 77: 5607-5620.
28. Sato B, Sommer M, Ito H, Arvin AM (2003) Requirement of varicella-zoster virus immediate-early 4 protein for viral replication. J Virol 77: 12369-12372.
29. Cohen JI, Cox E, Pesnicak L, Srinivas S, Krogmann T (2004) The varicellazoster virus open reading frame 63 latency-associated protein is critical for establishment of latency. J Virol 78: 11833-11840.
30. Baiker A, Bagowski C, Ito H, Sommer M, Zerboni L, et al. (2004) The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. J Virol 78: 1181-1194.
31. Sommer MH, Zagha E, Serrano OK, Ku CC, Zerboni L, et al. (2001) Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol 75: 8224-8239.
32. Mo C, Suen J, Sommer M, Arvin A (1999) Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth. J Virol 73: 4197-4207.
33. Yamagishi Y, Sadaoka T, Yoshii H, Somboonthum P, Imazawa T, et al. (2008) Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread. J Virol 82: 795-804.
34. Duus KM, Grose C (1996) Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J Virol 70: 8961-8971.
35. Maresova L, Kutinova L, Ludvikova V, Zak R, Mares M, et al. (2000) Characterization of interaction of gH and gL glycoproteins of varicella-zoster virus: their processing and trafficking. Journal of General Virology 81: 1545-1552.
36. Mallory S, Sommer M, Arvin AM (1998) Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids. Journal of Infectious Diseases 178: S22-S26.
37. Gharavi S, Sadeghizadeh M, Hosseinkhani S, Sabahi F (2007) A study of varicella zoster virus glycoprotein C regulatory region response to viral activators in vitro. Pak J Biol Sci 10: 2140-2145.
38. Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, et al. (1998) Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72: 965-974.
39. Mallory S, Sommer M, Arvin AM (1997) Mutational analysis of the role of glycoprotein I in Varicella-Zoster virus replication and its effects on glycoprotein E conformation and tracking. Journal of Virology 71: 8279-8288.
40. Moffat J, Ito H, Sommer M, Taylor S, Arvin AM (2002) Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells. J Virol 76: 8468-8471.
41. Stallings CL, Silverstein S (2005) Dissection of a novel nuclear localization signal in open reading frame 29 of varicella-zoster virus. J Virol 79: 13070-13081.
42. Roberts CR, Weir AC, Hay J, Straus SE, Ruyechan WT (1985) DNA-binding proteins present in varicella-zoster virus-infected cells. J Virol 55: 45-53.
43. Chaudhuri V, Sommer M, Rajamani J, Zerboni L, Arvin AM (2008) Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection. J Virol 82: 10231-10246.
44. Ito H, Sommer MH, Zerboni L, Baiker A, Sato B, et al. (2005) Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo. J Virol 79: 4819-4827.
45. Heineman TC, Cohen JI (1994) Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro. J Virol 68: 3317-3323.
46. Reddy SM, Cox E, Iofin I, Soong W, Cohen JI (1998) Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J Virol 72: 8083-8088.
47. Cohen JI, Seidel K (1994) Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro. J Virol 68: 7850-7858.
48. Heineman TC, Cohen JI (1995) The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22. J Virol 69: 7367-7370.
49. Sato H, Pesnicak L, Cohen JI (2002) Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency. J Virol 76: 3575-3578.
50. Cohen JI, Seidel KE (1995) Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro. Virology 206: 835-842.
51. Cohen JI, Seidel KE (1994) Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin. J Gen Virol 75(Pt 11): 3087-3093.
52. Cox E, Reddy S, Iofin I, Cohen JI (1998) Varicella-zoster virus ORF57, unlike its pseudorabies virus UL3.5 homolog, is dispensable for viral replication in cell culture. Virology 250: 205-209.
53. Yoshii H, Sadaoka K, Matsuura M, Nagaike K, Takahashi M, et al. (2008) Varicella-zoster virus ORF 58 gene is dispensable for viral replication in cell culture. Virol J 5: 54.
54. Cohen JI, Sato H, Srinivas S, Lekstrom K (2001) Varicella-zoster virus (VZV) ORF65 virion protein is dispensable for replication in cell culture and is phosphorylated by casein kinase II, but not by the VZV protein kinases. Virology 280: 62-71.
55. Che X, Zerboni L, Sommer MH, Arvin AM (2006) Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo. J Virol 80: 3238-3248.
56. Che XB, Berarducci B, Sommer M, Ruyechan WT, Arvin AM (2007) The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo. Journal of Virology 81: 3229-3239.
57. Klupp BG, Granzow H, Klopfleisch R, Fuchs W, Kopp M, et al. (2005) Functional analysis of the pseudorabies virus UL51 protein. Journal of Virology 79: 3831-3840.
58. Roizman B, Knipe DM, Whitley RJ (2007) Herpes simplex viruses. In: Knipe DM, Howley PM, eds. Fields Virology. 5th ed. PhiladelphiaPA: Lippincott Williams & Wilkins. pp 2399-2460.
59. Dunn W, Chou C, Li H, Hai R, Patterson D, et al. (2003) Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A 100: 14223-14228.
60. Ross J, Williams M, Cohen JI (1997) Disruption of the varicella-zoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro. Virology 234: 186-195.
61. Desloges N, Rahaus M, Wolff MH (2005) The varicella-zoster virus-mediated delayed host shutoff: open reading frame 17 has no major function, whereas immediate-early 63 protein represses heterologous gene expression. Microbes and Infection 7: 1519-1529.
62. Sato H, Callanan LD, Pesnicak L, Krogmann T, Cohen JI (2002) Varicellazoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37 degrees C but not 33 degrees C. Journal of Virology 76: 11012-11023.
63. Cohen JI, Nguyen H (1998) Varicella-zoster virus ORF61 deletion mutants replicate in cell culture, but a mutant with stop codons in ORF61 reverts to wildtype virus. Virology 246: 306-316.
64. Wang L, Sommer M, Rajamani J, Arvin AM (2009) Regulation of the ORF61 Promoter and ORF61 Functions in Varicella-Zoster Virus Replication and Pathogenesis. Journal of Virology 83: 7560-7572.
65. Heineman TC, Seidel K, Cohen JI (1996) The varicella-zoster virus ORF66 protein induces kinase activity and is dispensable for viral replication. Journal of Virology 70: 7312-7317.
66. Kinchington PR, Fite K, Seman A, Turse SE (2001) Virion association of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, requires expression of the VZV open reading frame 66 protein kinase. Journal of Virology 75: 9106-9113.
67. Erazo A, Yee MB, Osterrieder N, Kinchington PR (2008) Varicella-zoster virus open reading frame 66 protein kinase is required for efficient viral growth in primary human corneal stromal fibroblast cells. Journal of Virology 82: 7653-7665.
68. Schaap A, Fortin JF, Sommer M, Zerboni L, Stamatis S, et al. (2005) T-Cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. Journal of Virology 79: 12921-12933.
69. Marchini A, Liu H, Zhu H (2001) Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol 75: 1870-1878.
70. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5.
71. Tai YC, Speed TP (2006) A multivariate empirical Bayes statistic for replicated microarray time course data. Annals of Statistics 34: 2387-2412.